GSA Capital Partners’s IO Biotech IOBT Stock Holding History

GSA Capital Partners’s Portfolio IOBT Stock Details IOBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-348,352	Closed	-$20K	–	1948
2026 Q1	$20K	Buy	+348,352	New	+$119K	﹤0.01%	1641

GSA Capital Partners's IOBT Position: Q2 2026 in Review

GSA Capital Partners sold out of IO Biotech (IOBT) in Q2 2026, closing a stake of 348,352 shares — an estimated $20K sold.

GSA Capital Partners first reported a position in IOBT in Q1 2026 and held it in 1 quarter. The position peaked at $20K in Q1 2026. 0 funds tracked by Wall St. Rank hold IOBT as of Q2 2026.

GSA Capital Partners reported no remaining IO Biotech position as of Q2 2026 after selling out during the quarter.
GSA Capital Partners sold 348,352 IO Biotech shares in Q2 2026, an estimated $20K.
GSA Capital Partners first reported a position in IO Biotech in Q1 2026 and held it in 1 quarter.
GSA Capital Partners's IO Biotech position peaked at $20K in Q1 2026.
0 funds tracked by Wall St. Rank held IO Biotech as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.